Literature DB >> 15230712

Estimated cost of inpatient admissions and outpatient appointments for a population with epilepsy: a record linkage study.

Christopher Ll Morgan1, Michael P Kerr.   

Abstract

PURPOSE: This study describes the hospital costs for a population with epilepsy in 1 year (1999). The study was conducted in a defined geographic United Kingdom population of 424,000.
METHODS: A register of patients with epilepsy was constructed by using a variety of data sources that had undergone a process of record linkage. Hospital admissions were coded by using Healthcare Resource Group (HRG) and costed by using published National Health Service reference costs. A population of 3,892 people with epilepsy was recorded.
RESULTS: The cost of inpatient care for these patients with epilepsy was pound 2,537,386 ($4,135,939), an excess of pound 1,598,909 ($2,606,222) compared with the population as a whole. Of this, pound 320,182 ($521,897) was associated with a primary diagnosis of epilepsy, and pound 679,757 ($1,108,004) was associated with secondary diagnoses. Outpatient expenditure was pound 732,823 ($1,194,501).
CONCLUSIONS: This study demonstrates that people with epilepsy use excess resources and that this is not explained solely by either the direct or indirect effects of their epilepsy. These data may help in understanding of the complex issues surrounding the health economics of epilepsy. Copyright 2004 International League Against Epilepsy

Entities:  

Mesh:

Year:  2004        PMID: 15230712     DOI: 10.1111/j.0013-9580.2004.50103.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Pattern and outcome of admission to a medical oncology inpatient service.

Authors:  Faruk Tas; Andac Argon; Rian Disci; Erkan Topuz
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.